We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
Cap. Flow
+$288M
Cap. Flow %
8.77%
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78

Top Buys

Rank Stock Value
1
LIVN icon
LivaNova
LIVN
+$42.5M
2
MAPS
WM TECHNOLOGY INC A
MAPS
+$23.3M
3
SEER icon
Seer Inc
SEER
+$20.8M
4
GKOS icon
Glaukos
GKOS
+$17.9M
5
COO icon
Cooper Companies
COO
+$17.1M

Top Sells

Rank Stock Value
1
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$60.7M
2
NTLA icon
Intellia Therapeutics
NTLA
+$26.2M
3
ORGO icon
Organogenesis Holdings
ORGO
+$19.9M
4
LLY icon
Eli Lilly
LLY
+$15.1M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.25%
2 Consumer Staples 0.8%
3 Technology 0.71%
4 Industrials 0.71%
5 Materials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARS icon
326
Tarsus Pharmaceuticals
TARS
$3.07B
– –
-16,686
Closed -$484K
TSHA icon
327
Taysha Gene Therapies
TSHA
$2.05B
– –
-33,822
Closed -$717K
TWST icon
328
PUT
Twist Bioscience
TWST
$7.85B
– –
-20,000
Closed -$2.67M
VERO
329
DELISTED
Venus Concept
VERO
– –
-4,163
Closed -$2.14M
VERV
330
DELISTED
Verve Therapeutics
VERV
– –
-59,393
Closed -$3.58M
VXRT
331
CALL
DELISTED
Vaxart
VXRT
– –
-194,500
Closed -$1.46M
XGN icon
332
Exagen
XGN
$160M
– –
-51,502
Closed -$772K
ZNTL icon
333
Zentalis Pharmaceuticals
ZNTL
$307M
– –
-91,069
Closed -$4.84M
HURA
334
TuHURA Biosciences
HURA
$149M
– –
-16
Closed -$64K
ACHL
335
DELISTED
Achilles Therapeutics
ACHL
– –
-81,126
Closed -$794K
KA
336
DELISTED
Kineta, Inc. Common Stock
KA
– –
-9,742
Closed -$794K
OMIC
337
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
– –
-5,202
Closed -$4.29M
NSTG
338
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-100,000
Closed -$6.48M
MTACU
339
DELISTED
MedTech Acquisition Corporation Unit
MTACU
– –
-103,944
Closed -$1.04M
FNCH
340
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
– –
-2,385
Closed -$1.01M
CLVS
341
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-97,641
Closed -$566K
ZY
342
DELISTED
Zymergen Inc. Common Stock
ZY
– –
-214,577
Closed -$8.59M
FVAM
343
DELISTED
5:01 Acquisition Corp
FVAM
– –
-215,836
Closed -$2.15M
XENT
344
DELISTED
Intersect ENT, Inc
XENT
– –
-531,229
Closed -$9.08M
HCAQ
345
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
– –
-97,217
Closed -$958K
CMLTU
346
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
– –
-483,164
Closed -$5.29M
INOV
347
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
– –
-1,604,973
Closed -$60.7M
CHAQ.WS
348
DELISTED
Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
CHAQ.WS
– –
-153,960
Closed -$99K
CMIIU
349
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
– –
-1,045,043
Closed -$14.1M
CMAX
350
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
– –
-12,054
Closed -$4.67M
10 11 12 13
14

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.

  • Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
  • Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
  • Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
  • Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
  • Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
  • Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
  • Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.